Patent · US Active

Virion-like delivery particles for self-replicating RNA molecules

US11291635B2 · kind B2 · utility

41Cited by
31References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2011
Grant dateApr 5, 2022
Priority date
Expiry dateJul 6, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Nucleic acid immunisation is achieved by delivering a self-replicating RNA encapsulated within a small particle. The RNA encodes an immunogen of interest, and the particle may deliver this RNA by mimicking the delivery function of a natural RNA virus. Thus the invention provides a non-virion particle for in vivo delivery of RNA to a vertebrate cell, wherein the particle comprises a delivery material encapsulating a self-replicating RNA molecule which encodes an immunogen. These particles are useful as components in pharmaceutical compositions for immunising subjects against various diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.